GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
98 hedge funds and large institutions have $306M invested in GenMark Diagnostics, Inc in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.
28% more capital invested
Capital invested by funds: $239M → $306M (+$66.8M)
14% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 29
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 99 → 98 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$5.57M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$2.05M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.65M |
| 4 |
PWP
Private Wealth Partners
Mill Valley,
California
|
+$1.49M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$894K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$7.57M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.48M |
| 3 |
Millennium Management
New York
|
-$2.7M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$2.08M |
| 5 |
Two Sigma Investments
New York
|
-$1.6M |
GNMK Hedge Fund Activity: Q1 2018 in Review
98 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2018, worth a combined $306M — up 28% from $239M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of GNMK and 11 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 33 added.
The largest buyer was Casdin Capital, adding an estimated $5.57M. The largest seller was Jennison Associates, cutting an estimated $7.57M.
- 98 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2018, down from 99 in Q4 2017.
- Funds reported $306M of GenMark Diagnostics, Inc stock for Q1 2018, up 28% quarter-over-quarter.
- 11 funds opened new GenMark Diagnostics, Inc positions in Q1 2018 and 12 closed out, a net change of -1 holder.
- The largest GenMark Diagnostics, Inc buyer in Q1 2018 was Casdin Capital, an estimated $5.57M added.
- The largest GenMark Diagnostics, Inc seller in Q1 2018 was Jennison Associates, an estimated $7.57M sold.
Based on aggregated 13F filings for Q1 2018.